We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.
The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".
Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.
Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.
& Survival analysisi
Kaplan-Meier plots summarize results from analysis of correlation between mRNA expression level and patient survival. Patients were divided based on level of expression into one of the two groups "low" (under cut off) or "high" (over cut off). X-axis shows time for survival (years) and y-axis shows the probability of survival, where 1.0 corresponds to 100 percent.
RPL24 is not prognostic in Ovary Serous Cystadenocarcinoma (TCGA)
Stage:
Survival analysis
Current cut offi
Current cut-off shows the cut-off (FPKM) currently selected. It may be changed manually. When the current cut-off is changed, the vertical dashed line indicating cut-off, the interactive survival scatter plot and the Kaplan-Meier curve will be automatically adjusted to show results accordingly.
:
Best expression cut offi
Based on the FPKM value of each gene, patients were classified into two groups and association between prognosis (survival) and gene expression (FPKM) was examined. The best expression cut-off refers the FPKM value that yields maximal difference with regard to survival between the two groups at the lowest log-rank P-value. Best expression cut-off was selected based on survival analysis .
When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the best expression cut-off.
Median expression refers to the median FPKM value calculated based on the gene expression (FPKM) data from all patients in this dataset. When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the median expression.
Median follow up time refers to the median time (years) after diagnosis with this type of cancer, based on clinical data from all patients in this dataset.
: N/A
P scorei
Log-rank P value for Kaplan-Meier plot showing results from analysis of correlation between mRNA expression level and patient survival.
N/A
5-year survival highi
5-year survival for patients with higher expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
5-year survival lowi
5-year survival for patients with lower expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
TCGA RNA samplesi
RNA-seq data is reported as average FPKM (number Fragments Per Kilobase of exon per Million reads), generated by the The Cancer Genome Atlas (TCGA) .
Normal distribution across the dataset is visualized with box plots, shown as median and 25th and 75th percentiles. Points are displayed as outliers if they are above or below 1.5 times the interquartile range. FPKM values of the individual samples are presented next to the box plot.
Average pTPM
2197.6
Number of samples
349
Samples
Sample
Description
pTPM
TCGA-24-1471-01A
60 years, female, white, stage:Stage IIIC, alive, 36 days
7037.9
TCGA-04-1655-01A
49 years, female, white, stage:Stage IIIB, dead, 1380 days
5987.9
TCGA-29-1777-01A
47 years, female, white, stage:Stage IIIC, alive, 374 days
5044.6
TCGA-29-1761-01A
80 years, female, asian, stage:Stage IIIC, dead, 528 days
5007.7
TCGA-24-2038-01A
68 years, female, white, stage:Stage IIIA, dead, 1354 days
4912.4
TCGA-25-2393-01A
81 years, female, white, stage:Stage IIIC, dead, 1157 days
4871.0
TCGA-29-1703-01A
56 years, female, black or african american, stage:Stage IIIC, dead, 1815 days
4869.6
TCGA-04-1350-01A
46 years, female, white, stage:Stage IIIC, dead, 1946 days
4765.7
TCGA-13-0795-01A
66 years, female, white, stage:Stage IIIC, dead, 619 days
4760.4
TCGA-61-1721-01A
38 years, female, white, stage:Stage IV, alive, 338 days
4568.5
TCGA-29-1770-01A
54 years, female, white, stage:Stage IIIC, alive, 741 days
4544.7
TCGA-25-1634-01A
75 years, female, white, stage:Stage IIIC, dead, 1091 days
4511.6
TCGA-30-1853-01A
58 years, female, white, stage:Stage IIIC, dead, 1103 days
4481.1
TCGA-30-1892-01A
52 years, female, white, stage:Stage IIIC, dead, 1484 days
4360.4
TCGA-61-1733-01A
71 years, female, white, stage:Stage IIIC, alive, 967 days
4349.0
TCGA-24-1431-01A
67 years, female, white, stage:Stage IIIC, dead, 583 days
4265.0
TCGA-13-1409-01A
73 years, female, white, stage:Stage IIIC, dead, 1742 days
4245.5
TCGA-13-1495-01A
60 years, female, white, stage:Stage IIIC, dead, 2749 days
4205.9
TCGA-13-1407-01A
51 years, female, white, stage:Stage IIIC, alive, 2534 days
4202.8
TCGA-13-1507-01A
77 years, female, white, stage:Stage IIIC, dead, 1993 days
4126.8
TCGA-25-1316-01A
55 years, female, white, stage:Stage IIIC, dead, 1279 days
4101.6
TCGA-25-1877-01A
81 years, female, white, stage:Stage IIIC, dead, 730 days
4078.7
TCGA-09-0364-01A
80 years, female, white, stage:Stage IIC, dead, 887 days
3994.9
TCGA-30-1714-01A
68 years, female, white, stage:Stage IV, dead, 1158 days
3801.6
TCGA-OY-A56Q-01A
78 years, female, black or african american, stage:Stage IIA, alive, 576 days
3749.1
TCGA-23-1107-01A
59 years, female, white, stage:Stage IV, dead, 9 days
3737.9
TCGA-29-1766-01A
74 years, female, white, stage:Stage IIIC, dead, 1199 days
3697.1
TCGA-09-2048-01A
63 years, female, white, stage:Stage IIIC, dead, 138 days
3622.7
TCGA-25-1630-01A
73 years, female, white, stage:Stage IIIC, dead, 1162 days
3618.1
TCGA-24-1474-01A
57 years, female, black or african american, stage:Stage IIIC, dead, 676 days
3575.4
TCGA-24-2033-01A
87 years, female, white, stage:Stage IIIC, dead, 562 days
3573.9
TCGA-24-0979-01A
53 years, female, white, stage:Stage IV, dead, 1264 days
3563.1
TCGA-09-0367-01A
67 years, female, native hawaiian or other pacific islander, stage:Stage IIIC, dead, 547 days
3557.6
TCGA-29-1696-01A
43 years, female, white, stage:Stage IIIC, dead, 1032 days
3550.7
TCGA-13-1506-01A
45 years, female, white, stage:Stage IIIC, dead, 1039 days
3547.0
TCGA-30-1891-01A
61 years, female, white, stage:Stage IIIC, dead, 914 days
3528.4
TCGA-10-0927-01A
65 years, female, stage:Stage IIIC, dead, 2490 days
3503.2
TCGA-29-1701-01A
56 years, female, white, stage:Stage IIIC, dead, 515 days
3445.5
TCGA-24-1553-01A
53 years, female, white, stage:Stage IIIB, dead, 1767 days
3440.5
TCGA-25-1632-01A
68 years, female, white, stage:Stage IV, dead, 1799 days
3440.0
TCGA-13-0762-01A
65 years, female, white, stage:Stage IIIC, alive, 3400 days
3421.3
TCGA-25-1323-01A
72 years, female, white, stage:Stage IIIC, dead, 395 days
3373.9
TCGA-29-1769-01A
40 years, female, white, stage:Stage IIIC, alive, 699 days
3367.5
TCGA-13-1404-01A
48 years, female, white, stage:Stage IIIC, alive, 2469 days
3357.9
TCGA-61-2002-01A
46 years, female, white, stage:Stage IIIC, alive, 547 days
3352.6
TCGA-24-1418-01A
68 years, female, white, stage:Stage IIIC, alive, 243 days
3257.6
TCGA-29-1690-01A
66 years, female, white, stage:Stage IIIC, dead, 1448 days
3211.6
TCGA-13-1510-01A
62 years, female, white, stage:Stage IIIC, dead, 1359 days
3209.5
TCGA-04-1341-01A
85 years, female, white, stage:'--, alive, 33 days
3202.0
TCGA-61-1725-01A
40 years, female, white, stage:Stage IIIC, alive, 956 days
3189.0
TCGA-24-0982-01A
77 years, female, white, stage:Stage IIIC, dead, 679 days
3163.0
TCGA-13-1487-01A
74 years, female, white, stage:Stage IV, dead, 681 days
3153.5
TCGA-24-1616-01A
56 years, female, white, stage:Stage IIIC, dead, 1163 days
3152.0
TCGA-04-1343-01A
72 years, female, white, stage:Stage IV, dead, 361 days
3151.6
TCGA-61-1914-01A
65 years, female, stage:Stage IIIC, alive, 1722 days
3124.5
TCGA-09-1673-01A
50 years, female, white, stage:Stage IV, alive, 92 days
3114.8
TCGA-29-1768-01A
50 years, female, white, stage:Stage IV, dead, 952 days
3086.7
TCGA-13-0920-01A
65 years, female, white, stage:Stage IIIC, dead, 1484 days
3075.3
TCGA-13-0724-01A
72 years, female, white, stage:Stage IV, dead, 83 days
3035.5
TCGA-61-2000-01A
67 years, female, white, stage:Stage IIIC, alive, 441 days
3014.2
TCGA-23-1809-01A
63 years, female, white, stage:Stage IIC, alive, 16 days
2983.9
TCGA-13-0727-01A
71 years, female, white, stage:Stage IIIC, dead, 462 days
2971.7
TCGA-04-1347-01A
81 years, female, white, stage:Stage IV, alive, 1919 days
2969.3
TCGA-13-0766-01A
42 years, female, white, stage:Stage IIIC, dead, 1725 days
2968.3
TCGA-25-1870-01A
59 years, female, white, stage:Stage IIIC, dead, 455 days
2925.5
TCGA-61-2092-01A
57 years, female, white, stage:Stage IIIC, alive, 1573 days
2874.4
TCGA-5X-AA5U-01A
61 years, female, black or african american, stage:Stage IIC, alive, 361 days
2849.1
TCGA-23-1113-01A
48 years, female, white, stage:Stage IV, dead, 949 days
2848.5
TCGA-13-1489-01A
70 years, female, white, stage:Stage IIIC, dead, 2553 days
2839.1
TCGA-10-0937-01A
44 years, female, white, stage:Stage IIIC, dead, 608 days
2814.4
TCGA-61-2109-01A
40 years, female, white, stage:Stage IIIC, dead, 629 days
2787.4
TCGA-24-1464-01A
70 years, female, white, stage:Stage IIIC, dead, 379 days
2781.8
TCGA-WR-A838-01A
72 years, female, black or african american, stage:Stage IIIC, dead, 304 days
2775.2
TCGA-25-1312-01A
69 years, female, white, stage:Stage IV, dead, 31 days
2765.8
TCGA-09-1666-01A
57 years, female, white, stage:Stage IIIC, alive, 1752 days
2746.0
TCGA-23-2077-01A
45 years, female, white, stage:Stage IIIC, alive, 3525 days
2713.6
TCGA-29-2425-01A
60 years, female, white, stage:Stage IIIC, alive, 1977 days
2701.2
TCGA-13-1477-01A
49 years, female, white, stage:Stage IV, dead, 1662 days
2697.3
TCGA-13-1483-01A
61 years, female, white, stage:Stage IIIC, dead, 895 days
2697.0
TCGA-10-0931-01A
44 years, female, white, stage:Stage IIIC, dead, 1000 days
2695.5
TCGA-61-1911-01A
55 years, female, white, stage:Stage IIA, alive, 1293 days
2689.3
TCGA-13-1403-01A
48 years, female, white, stage:Stage IIIC, dead, 2345 days
2663.6
TCGA-61-2008-01A
40 years, female, asian, stage:Stage IIC, alive, 932 days
2644.2
TCGA-24-1544-01A
71 years, female, black or african american, stage:Stage IIIC, dead, 820 days
2635.7
TCGA-24-1842-01A
49 years, female, white, stage:Stage IIIC, alive, 253 days
2631.5
TCGA-13-0888-01A
78 years, female, white, stage:Stage IIIC, dead, 2811 days
2630.0
TCGA-36-1574-01A
48 years, female, asian, stage:Stage IIIC, alive, 686 days
2625.1
TCGA-09-1670-01A
57 years, female, white, stage:Stage IIIA, alive, 547 days
2622.5
TCGA-24-0966-01A
78 years, female, black or african american, stage:Stage IIIC, alive, 232 days
2616.9
TCGA-10-0933-01A
77 years, female, white, stage:Stage IIIC, dead, 446 days
2600.5
TCGA-24-2024-01A
72 years, female, black or african american, stage:Stage IIIC, dead, 1769 days
2595.8
TCGA-25-1328-01A
38 years, female, white, stage:Stage IIIC, dead, 2009 days
2580.8
TCGA-24-1923-01A
51 years, female, white, stage:Stage IIIC, dead, 690 days
2575.6
TCGA-30-1718-01A
44 years, female, white, stage:Stage IIIC, dead, 1579 days
2570.5
TCGA-25-2396-01A
71 years, female, white, stage:Stage IIIC, dead, 92 days
2561.7
TCGA-13-0924-01A
45 years, female, white, stage:Stage IV, alive, 2614 days
2552.6
TCGA-36-1577-01A
43 years, female, asian, stage:Stage IIC, alive, 783 days
2528.9
TCGA-57-1586-01A
66 years, female, white, stage:Stage IIIC, alive, 679 days
2523.1
TCGA-04-1364-01A
61 years, female, white, stage:Stage IIIC, dead, 1024 days
2520.9
TCGA-13-0730-01A
71 years, female, white, stage:Stage IIIC, dead, 542 days
2516.7
TCGA-23-1028-01A
43 years, female, white, stage:Stage IIIC, alive, 1503 days
2511.2
TCGA-61-1998-01A
48 years, female, white, stage:Stage IIIC, alive, 168 days
2509.9
TCGA-36-1569-01A
52 years, female, white, stage:Stage IIIC, alive, 885 days
2508.8
TCGA-61-2110-01A
56 years, female, white, stage:Stage IIIC, dead, 1354 days
2504.7
TCGA-24-1567-01A
54 years, female, white, stage:Stage IIIB, dead, 524 days
2495.9
TCGA-04-1519-01A
48 years, female, stage:Stage IIIC, alive, 24 days
2481.3
TCGA-23-1027-01A
48 years, female, white, stage:Stage IIIC, dead, 976 days
2472.2
TCGA-57-1583-01A
57 years, female, black or african american, stage:Stage IIIC, dead, 346 days
2470.2
TCGA-13-0887-01A
42 years, female, white, stage:Stage IIIC, dead, 2028 days
2468.6
TCGA-29-1776-01A
63 years, female, black or african american, stage:Stage IIIC, alive, 360 days
2462.2
TCGA-24-1434-01A
59 years, female, white, stage:Stage IIIC, dead, 568 days
2457.5
TCGA-23-1022-01A
67 years, female, white, stage:Stage IIIC, dead, 1511 days
2454.5
TCGA-04-1542-01A
52 years, female, white, stage:Stage IIIB, dead, 2561 days
2449.7
TCGA-24-1560-01A
51 years, female, white, stage:Stage IIIC, dead, 1341 days
2442.7
TCGA-13-1505-01A
63 years, female, white, stage:Stage IIIC, alive, 1998 days
2437.8
TCGA-13-A5FT-01A
67 years, female, black or african american, stage:Stage IIIC, alive, 2143 days
2424.6
TCGA-29-2428-01A
58 years, female, white, stage:Stage IIIC, alive, 1372 days
2405.3
TCGA-13-0804-01A
73 years, female, white, stage:Stage IIIC, dead, 1073 days
2397.1
TCGA-24-1467-01A
51 years, female, white, stage:Stage IIIC, dead, 3224 days
2386.8
TCGA-29-1774-01A
82 years, female, white, stage:Stage IIIC, alive, 527 days
2374.4
TCGA-61-1738-01A
60 years, female, black or african american, stage:Stage IIIC, dead, 1089 days
2362.2
TCGA-13-0765-01A
50 years, female, white, stage:Stage IIIC, dead, 1389 days
2348.6
TCGA-23-1122-01A
53 years, female, white, stage:Stage IIIC, dead, 1189 days
2336.4
TCGA-20-1682-01A
56 years, female, white, stage:Stage IIIC, alive, 837 days
2329.8
TCGA-24-1604-01A
66 years, female, white, stage:Stage IIIC, dead, 2688 days
2323.6
TCGA-04-1338-01A
78 years, female, white, stage:Stage IIIC, alive, 1418 days
2323.1
TCGA-23-1030-01A
64 years, female, white, stage:Stage IIIC, alive, 886 days
2316.0
TCGA-24-2280-01A
74 years, female, white, stage:Stage IIIC, alive, 2143 days
2313.6
TCGA-29-1762-01A
59 years, female, white, stage:Stage IV, dead, 2634 days
2304.1
TCGA-04-1362-01A
59 years, female, white, stage:Stage IIC, dead, 1348 days
2300.0
TCGA-25-1631-01A
73 years, female, white, stage:Stage IIIC, dead, 9 days
2299.4
TCGA-61-1918-01A
45 years, female, white, stage:Stage IV, dead, 479 days
2282.9
TCGA-24-1413-01A
51 years, female, white, stage:Stage IIIC, alive, 192 days
2281.2
TCGA-20-1683-01A
65 years, female, white, stage:Stage IIIC, alive, 772 days
2274.5
TCGA-13-0800-01A
52 years, female, white, stage:Stage IIIC, alive, 2661 days
2253.0
TCGA-23-1118-01A
45 years, female, white, stage:Stage IIIC, alive, 2616 days
2252.5
TCGA-59-2363-01A
40 years, female, asian, stage:Stage IIIA, alive, 165 days
2236.7
TCGA-24-1417-01A
54 years, female, white, stage:Stage IV, alive, 238 days
2219.5
TCGA-25-1627-01A
73 years, female, white, stage:Stage IIIC, dead, 394 days
2219.0
TCGA-23-1110-01A
42 years, female, white, stage:Stage IIIC, alive, 1658 days
2215.6
TCGA-24-1562-01A
67 years, female, white, stage:Stage IIIC, dead, 1384 days
2211.6
TCGA-13-0911-01A
55 years, female, white, stage:Stage IV, dead, 1355 days
2210.1
TCGA-61-2098-01A
62 years, female, white, stage:Stage IIIC, alive, 1993 days
2194.0
TCGA-VG-A8LO-01A
55 years, female, black or african american, stage:Stage IV, dead, 24 days
2192.4
TCGA-29-1697-01A
62 years, female, white, stage:Stage IIIC, dead, 949 days
2184.0
TCGA-20-1686-01A
75 years, female, white, stage:Stage IIIC, alive, 89 days
2182.2
TCGA-61-1728-01A
59 years, female, white, stage:Stage IV, alive, 848 days
2177.4
TCGA-23-1111-01A
63 years, female, white, stage:Stage IIIC, alive, 98 days
2175.7
TCGA-13-1498-01A
73 years, female, white, stage:Stage IIIC, dead, 2012 days
2163.2
TCGA-13-0725-01A
44 years, female, white, stage:Stage IIIC, dead, 377 days
2158.3
TCGA-23-1109-01A
62 years, female, white, stage:Stage IIIC, dead, 1562 days
2153.2
TCGA-29-2414-01A
75 years, female, white, stage:Stage IIIC, dead, 2621 days
2147.9
TCGA-24-1565-01A
74 years, female, white, stage:Stage IIIC, dead, 312 days
2141.8
TCGA-13-0923-01A
74 years, female, white, stage:Stage IIIC, alive, 2547 days
2130.9
TCGA-59-2355-01A
58 years, female, white, stage:Stage IV, dead, 65 days
2129.6
TCGA-61-2009-01A
65 years, female, white, stage:Stage IIIC, alive, 1212 days
2118.9
TCGA-09-0366-01A
55 years, female, white, stage:Stage IIIC, dead, 1757 days
2115.0
TCGA-61-2111-01A
61 years, female, white, stage:Stage IV, alive, 3825 days
2109.9
TCGA-13-0897-01A
54 years, female, white, stage:Stage IIIC, dead, 2182 days
2101.5
TCGA-24-2020-01A
67 years, female, white, stage:Stage IIIC, dead, 4624 days
2099.3
TCGA-29-1710-01A
54 years, female, white, stage:Stage IIIC, dead, 951 days
2096.5
TCGA-29-1784-01A
55 years, female, white, stage:Stage IIIC, alive, 163 days
2092.6
TCGA-24-1844-01A
64 years, female, white, stage:Stage IIIC, alive, 113 days
2082.0
TCGA-29-1778-01A
77 years, female, white, stage:Stage IIIC, alive, 454 days
2068.5
TCGA-31-1946-01A
30 years, female, stage:Stage IIIC, alive, 918 days
2067.2
TCGA-61-1910-01A
56 years, female, white, stage:Stage IIC, alive, 1127 days
2056.2
TCGA-13-2060-01A
51 years, female, white, stage:Stage IV, alive, 2369 days
2041.9
TCGA-30-1860-01A
58 years, female, white, stage:Stage IIIC, dead, 1366 days
2007.5
TCGA-10-0938-01A
80 years, female, white, stage:Stage IIIC, dead, 636 days
2004.2
TCGA-36-1576-01A
76 years, female, stage:Stage IIIC, alive, 915 days
2003.8
TCGA-24-2023-01A
54 years, female, white, stage:Stage IIIA, dead, 1364 days
2000.2
TCGA-23-1123-01A
59 years, female, white, stage:Stage IIIC, dead, 1018 days
1997.9
TCGA-09-1669-01A
54 years, female, white, stage:Stage IIIA, alive, 928 days
1993.2
TCGA-24-2290-01A
56 years, female, white, stage:Stage IIIC, dead, 1102 days
1983.3
TCGA-13-0883-01A
61 years, female, white, stage:Stage IIIC, dead, 2097 days
1982.7
TCGA-25-2398-01A
71 years, female, white, stage:Stage IIIC, dead, 1369 days
1982.3
TCGA-24-1563-01A
66 years, female, black or african american, stage:Stage IIIC, dead, 1451 days
1981.6
TCGA-13-0720-01A
48 years, female, white, stage:Stage IIIC, dead, 1355 days
1961.8
TCGA-29-2427-01A
60 years, female, white, stage:Stage IIIC, alive, 1900 days
1960.6
TCGA-20-0991-01A
78 years, female, white, stage:Stage IIB, alive, 797 days
1954.7
TCGA-29-A5NZ-01A
66 years, female, black or african american, stage:Stage IIIC, dead, 1088 days
1952.4
TCGA-25-2400-01A
76 years, female, white, stage:Stage IIIC, dead, 1278 days
1949.9
TCGA-24-1930-01A
53 years, female, white, stage:Stage IIIC, dead, 2467 days
1929.9
TCGA-29-1694-01A
45 years, female, white, stage:Stage IIIC, dead, 1187 days
1925.2
TCGA-30-1857-01A
64 years, female, white, stage:Stage IV, dead, 8 days
1918.5
TCGA-23-1023-01A
65 years, female, white, stage:Stage IIIC, alive, 1233 days
1906.5
TCGA-24-1428-01A
50 years, female, white, stage:Stage IIIC, alive, 529 days
1898.3
TCGA-30-1861-01A
74 years, female, white, stage:Stage IIIC, dead, 1058 days
1891.4
TCGA-20-1687-01A
46 years, female, white, stage:Stage IV, alive, 81 days
1890.4
TCGA-04-1361-01A
57 years, female, white, stage:Stage IIIB, alive, 989 days
1888.7
TCGA-24-1843-01A
66 years, female, white, stage:Stage IIIC, alive, 106 days
1877.6
TCGA-24-1603-01A
53 years, female, white, stage:Stage IIIB, dead, 2742 days
1868.8
TCGA-61-2101-01A
55 years, female, white, stage:Stage IIIC, dead, 1688 days
1866.7
TCGA-13-0906-01A
50 years, female, white, stage:Stage IIIC, alive, 3619 days
1862.1
TCGA-25-1317-01A
66 years, female, white, stage:Stage IIIC, dead, 61 days
1860.8
TCGA-24-1846-01A
45 years, female, stage:Stage IIIC, alive, 133 days
1858.2
TCGA-13-1501-01A
50 years, female, white, stage:Stage IV, dead, 1314 days
1854.7
TCGA-09-2051-01A
42 years, female, white, stage:Stage IIIC, alive, 1919 days
1853.9
TCGA-24-2267-01A
58 years, female, white, stage:Stage IIB, dead, 1446 days
1844.2
TCGA-30-1866-01A
61 years, female, white, stage:Stage IV, dead, 1114 days
1841.6
TCGA-29-1705-01A
47 years, female, white, stage:Stage IIIC, dead, 555 days
1837.4
TCGA-13-0891-01A
73 years, female, white, stage:Stage IV, dead, 3128 days
1828.1
TCGA-61-1907-01A
63 years, female, white, stage:Stage IIIC, alive, 952 days
1826.5
TCGA-23-2078-01A
66 years, female, white, stage:Stage IIIC, alive, 2661 days
1823.0
TCGA-36-1570-01A
49 years, female, white, stage:Stage IIIC, alive, 655 days
1822.6
TCGA-29-1783-01A
58 years, female, white, stage:Stage IIIC, alive, 220 days
1815.5
TCGA-30-1862-01A
65 years, female, white, stage:Stage IV, dead, 186 days
1813.5
TCGA-36-1580-01A
82 years, female, stage:Stage IIIC, dead, 737 days
1812.4
TCGA-25-1313-01A
62 years, female, white, stage:Stage IV, dead, 820 days
1801.1
TCGA-23-1116-01A
83 years, female, white, stage:Stage IIIC, dead, 592 days
1790.4
TCGA-23-1120-01A
60 years, female, white, stage:Stage IIIC, alive, 130 days
1771.9
TCGA-24-1924-01A
65 years, female, white, stage:Stage IIIC, dead, 919 days
1761.0
TCGA-25-1315-01A
50 years, female, white, stage:Stage IIIC, dead, 1583 days
1753.0
TCGA-24-1419-01A
62 years, female, white, stage:Stage IIIC, alive, 239 days
1750.8
TCGA-59-2350-01A
44 years, female, stage:Stage IV, dead, 679 days
1747.1
TCGA-25-1633-01A
64 years, female, white, stage:Stage IIIC, dead, 1891 days
1745.4
TCGA-29-1785-01A
55 years, female, white, stage:Stage IIIC, dead, 1104 days
1743.5
TCGA-31-1956-01A
60 years, female, white, stage:Stage IIIB, alive, 1342 days
1741.7
TCGA-13-0886-01A
67 years, female, white, stage:Stage IIIC, alive, 4665 days
1737.0
TCGA-36-1568-01A
52 years, female, stage:Stage IIIC, alive, 875 days
1729.9
TCGA-04-1365-01A
87 years, female, white, stage:Stage IIIB, alive, 947 days
1729.5
TCGA-23-1024-01A
52 years, female, white, stage:Stage IV, alive, 468 days
1703.3
TCGA-13-0726-01A
55 years, female, white, stage:Stage IIIC, dead, 949 days
1701.4
TCGA-24-2026-01A
79 years, female, white, stage:Stage IIIC, dead, 1059 days
1695.4
TCGA-24-1422-01A
82 years, female, black or african american, stage:Stage IIIC, dead, 23 days
1695.1
TCGA-61-1995-01A
43 years, female, white, stage:Stage IIIC, alive, 61 days
1694.7
TCGA-25-1623-01A
71 years, female, white, stage:Stage IV, dead, 565 days
1692.6
TCGA-23-1119-01A
64 years, female, white, stage:Stage IIIC, alive, 3953 days
1678.0
TCGA-25-1318-01A
54 years, female, white, stage:Stage IIIC, dead, 1064 days
1677.4
TCGA-09-0369-01A
56 years, female, white, stage:Stage IIIC, dead, 1082 days
1667.2
TCGA-61-1737-01A
42 years, female, white, stage:Stage IV, alive, 1364 days
1658.0
TCGA-24-1103-01A
50 years, female, black or african american, stage:Stage IIIC, dead, 1646 days
1645.9
TCGA-24-1424-01A
67 years, female, white, stage:Stage IIIC, alive, 183 days
1643.4
TCGA-24-1550-01A
49 years, female, white, stage:Stage IIIC, dead, 1249 days
1642.6
TCGA-29-1688-01A
39 years, female, white, stage:Stage IIIC, dead, 2400 days
1642.3
TCGA-23-2084-01A
45 years, female, white, stage:Stage IV, dead, 1516 days
1637.3
TCGA-57-1582-01A
50 years, female, white, stage:Stage IIIC, dead, 731 days
1635.6
TCGA-13-0714-01A
55 years, female, white, stage:Stage IV, dead, 189 days
1635.2
TCGA-13-1485-01A
48 years, female, white, stage:Stage IV, dead, 629 days
1631.8
TCGA-13-1405-01A
49 years, female, white, stage:Stage IV, dead, 868 days
1630.8
TCGA-24-1845-01A
42 years, female, white, stage:Stage IIIC, alive, 116 days
1620.1
TCGA-25-2409-01A
71 years, female, white, stage:Stage IV, dead, 821 days
1615.4
TCGA-61-1900-01A
51 years, female, black or african american, stage:Stage IIIB, alive, 176 days
1614.9
TCGA-24-1416-01A
34 years, female, white, stage:Stage IV, alive, 194 days
1614.8
TCGA-31-1944-01A
47 years, female, white, stage:Stage IIIC, alive, 1386 days
1612.1
TCGA-57-1585-01A
57 years, female, white, stage:Stage IIIC, dead, 53 days
1603.9
TCGA-24-2298-01A
55 years, female, white, stage:Stage IIIC, dead, 1620 days
1598.6
TCGA-24-1427-01A
58 years, female, stage:Stage IIIC, alive, 147 days
1595.1
TCGA-13-1496-01A
65 years, female, white, stage:Stage IIIC, dead, 129 days
1578.3
TCGA-25-2404-01A
38 years, female, american indian or alaska native, stage:Stage IIIC, dead, 883 days
1576.3
TCGA-20-0987-01A
61 years, female, white, stage:Stage IIIC, dead, 701 days
1560.1
TCGA-25-1626-01A
65 years, female, white, stage:Stage IIIC, dead, 518 days
1554.4
TCGA-25-1326-01A
61 years, female, white, stage:Stage IIIC, dead, 1249 days
1551.6
TCGA-13-1411-01A
81 years, female, white, stage:Stage IIIC, dead, 531 days
1551.3
TCGA-24-2281-01A
68 years, female, white, stage:Stage IIA, alive, 1357 days
1547.4
TCGA-24-1435-01A
57 years, female, white, stage:Stage IIIC, dead, 1324 days
1546.4
TCGA-09-1662-01A
58 years, female, white, stage:Stage IV, dead, 2717 days
1535.4
TCGA-29-1763-01A
43 years, female, black or african american, stage:Stage IIC, alive, 2032 days
1535.3
TCGA-13-1410-01A
57 years, female, white, stage:Stage IV, alive, 2464 days
1531.5
TCGA-25-2401-01A
64 years, female, white, stage:Stage IIIC, dead, 90 days
1519.8
TCGA-59-2351-01A
51 years, female, white, stage:Stage IIIC, alive, 3532 days
1516.8
TCGA-24-1105-01A
36 years, female, white, stage:Stage IIIC, dead, 1442 days
1515.8
TCGA-31-1953-01A
52 years, female, asian, stage:Stage IIIC, alive, 204 days
1512.2
TCGA-04-1651-01A
53 years, female, white, stage:Stage IIIC, dead, 1102 days
1510.9
TCGA-61-1919-01A
58 years, female, white, stage:Stage IIIC, dead, 1161 days
1509.6
TCGA-24-2261-01A
76 years, female, white, stage:Stage IIIC, dead, 24 days
1508.9
TCGA-24-2254-01A
66 years, female, white, stage:Stage IIIC, dead, 1736 days
1503.1
TCGA-24-1558-01A
73 years, female, white, stage:Stage IIIC, dead, 594 days
1499.1
TCGA-25-1329-01A
76 years, female, white, stage:Stage IIIC, dead, 457 days
1495.1
TCGA-13-1488-01A
59 years, female, white, stage:Stage IV, dead, 2154 days
1492.3
TCGA-24-1546-01A
46 years, female, white, stage:Stage IIIC, dead, 1955 days
1489.6
TCGA-61-2102-01A
74 years, female, white, stage:Stage IIIC, dead, 197 days
1482.2
TCGA-29-1691-01A
51 years, female, white, stage:Stage IIIC, dead, 1470 days
1481.1
TCGA-04-1332-01A
70 years, female, white, stage:Stage IIIC, dead, 1247 days
1480.9
TCGA-24-1430-01A
68 years, female, white, stage:Stage IIIC, dead, 863 days
1478.2
TCGA-13-1408-01A
59 years, female, white, stage:Stage IIIC, dead, 1680 days
1470.1
TCGA-25-1319-01A
73 years, female, white, stage:Stage IIIC, dead, 1977 days
1464.2
TCGA-24-1104-01A
56 years, female, white, stage:Stage IV, dead, 1933 days
1463.0
TCGA-24-1928-01A
77 years, female, white, stage:Stage IIIC, dead, 336 days
1456.1
TCGA-29-1781-01A
69 years, female, white, stage:Stage IIIC, alive, 255 days
1452.7
TCGA-24-1469-01A
71 years, female, white, stage:Stage IIIC, alive, 277 days
1445.2
TCGA-36-1571-01A
53 years, female, white, stage:Stage IIIB, dead, 695 days
1407.9
TCGA-13-1497-01A
47 years, female, white, stage:Stage IIIC, alive, 3871 days
1401.8
TCGA-24-2027-01A
51 years, female, white, stage:Stage IV, dead, 3337 days
1396.9
TCGA-24-1847-01A
45 years, female, white, stage:Stage IV, alive, 343 days
1382.0
TCGA-61-1724-01A
47 years, female, white, stage:Stage IIIC, dead, 637 days
1378.5
TCGA-24-2035-01A
65 years, female, white, stage:Stage IIIC, dead, 857 days
1375.1
TCGA-04-1514-01A
45 years, female, white, stage:Stage IIIA, dead, 1720 days
1367.3
TCGA-25-1320-01A
65 years, female, white, stage:Stage IIIC, dead, 1155 days
1356.1
TCGA-10-0928-01A
71 years, female, white, stage:Stage IIIC, dead, 563 days
1350.8
TCGA-61-2097-01A
71 years, female, white, stage:Stage IIC, alive, 1844 days
1347.4
TCGA-24-1423-01A
61 years, female, white, stage:Stage IIIC, alive, 190 days
1343.7
TCGA-57-1994-01A
63 years, female, white, stage:'--, alive, 761 days
1330.2
TCGA-25-1322-01A
62 years, female, white, stage:Stage IV, dead, 91 days
1324.1
TCGA-24-1552-01A
77 years, female, white, stage:Stage IIIC, dead, 1259 days
1311.8
TCGA-04-1536-01A
60 years, female, black or african american, stage:Stage IV, dead, 885 days
1297.6
TCGA-13-0916-01A
49 years, female, white, stage:Stage IIIC, alive, 1785 days
1292.3
TCGA-29-1693-01A
72 years, female, white, stage:Stage IIIC, alive, 3096 days
1286.6
TCGA-25-2399-01A
80 years, female, white, stage:Stage IIIC, dead, 608 days
1277.0
TCGA-09-2054-01A
58 years, female, black or african american, stage:Stage IIIC, dead, 637 days
1276.2
TCGA-13-1499-01A
56 years, female, white, stage:Stage IIIC, alive, 3500 days
1275.2
TCGA-59-A5PD-01A
55 years, female, black or african american, stage:Stage IC, dead, 624 days
1272.6
TCGA-13-0885-01A
70 years, female, white, stage:Stage IIIC, alive, 3388 days
1270.9
TCGA-24-1425-01A
45 years, female, white, stage:Stage IIIC, alive, 181 days
1266.6
TCGA-59-2354-01A
63 years, female, white, stage:Stage IIIC, dead, 1046 days
1263.2
TCGA-24-1557-01A
49 years, female, white, stage:Stage IIIC, dead, 1213 days
1262.9
TCGA-13-1509-01A
64 years, female, white, stage:Stage IV, alive, 2438 days
1262.5
TCGA-61-1741-01A
76 years, female, white, stage:Stage IIIB, dead, 1024 days
1261.8
TCGA-13-0768-01A
73 years, female, white, stage:Stage IIIC, dead, 1784 days
1254.6
TCGA-29-1711-01A
45 years, female, black or african american, stage:Stage IIIC, alive, 1053 days
1252.1
TCGA-57-1584-01A
47 years, female, white, stage:Stage IIIC, alive, 643 days
1250.4
TCGA-24-1850-01A
72 years, female, white, stage:Stage IIIC, alive, 168 days
1249.3
TCGA-04-1530-01A
68 years, female, white, stage:Stage IIIC, dead, 3622 days
1224.3
TCGA-36-1581-01A
63 years, female, white, stage:Stage IIC, alive, 751 days
1213.8
TCGA-31-1950-01A
76 years, female, white, stage:Stage IIIC, alive, 571 days
1213.1
TCGA-13-0797-01A
49 years, female, white, stage:Stage IIIC, alive, 2121 days
1203.7
TCGA-25-1628-01A
67 years, female, white, stage:Stage IIIC, dead, 627 days
1193.7
TCGA-61-2104-01A
53 years, female, white, stage:Stage IIC, alive, 2338 days
1189.6
TCGA-25-1321-01A
65 years, female, white, stage:Stage IIIC, dead, 1033 days
1183.1
TCGA-25-1635-01A
71 years, female, white, stage:Stage IIIC, dead, 1583 days
1173.7
TCGA-24-1549-01A
58 years, female, white, stage:Stage IIIB, dead, 1721 days
1173.1
TCGA-59-2348-01A
59 years, female, white, stage:Stage IIIC, alive, 5481 days
1145.4
TCGA-59-2352-01A
78 years, female, white, stage:Stage IIIC, dead, 286 days
1144.1
TCGA-24-0968-01A
59 years, female, white, stage:Stage IIIC, dead, 598 days
1136.5
TCGA-24-2036-01A
50 years, female, white, stage:Stage IIIA, dead, 1947 days
1124.1
TCGA-61-2003-01A
53 years, female, white, stage:Stage IIIC, alive, 122 days
1105.0
TCGA-04-1648-01A
57 years, female, white, stage:Stage IIIC, dead, 871 days
1086.5
TCGA-24-1426-01A
43 years, female, white, stage:Stage IIIC, alive, 163 days
1055.6
TCGA-09-2045-01A
50 years, female, asian, stage:Stage IV, dead, 1069 days
1050.8
TCGA-24-2297-01A
56 years, female, white, stage:Stage IIIC, dead, 1699 days
1031.2
TCGA-24-1551-01A
53 years, female, white, stage:Stage IIIC, dead, 1579 days
1021.0
TCGA-25-2042-01A
60 years, female, american indian or alaska native, stage:Stage IIIC, dead, 396 days
1009.5
TCGA-31-1951-01A
58 years, female, white, stage:Stage IIIC, alive, 684 days
1009.2
TCGA-61-2088-01A
51 years, female, white, stage:Stage IIIC, alive, 145 days
1003.1
TCGA-61-2113-01A
53 years, female, white, stage:Stage IIC, dead, 676 days
1001.4
TCGA-24-2288-01A
70 years, female, white, stage:Stage IIIC, dead, 25 days
986.7
TCGA-29-1695-01A
62 years, female, white, stage:Stage IIIC, dead, 1229 days
976.9
TCGA-57-1993-01A
56 years, female, white, stage:Stage IIIC, alive, 763 days
973.4
TCGA-04-1331-01A
78 years, female, white, stage:Stage IIIC, dead, 1336 days
966.6
TCGA-13-1492-01A
66 years, female, white, stage:Stage IIIC, dead, 3819 days
949.3
TCGA-13-1511-01A
52 years, female, asian, stage:Stage IV, dead, 1650 days
930.0
TCGA-31-1959-01A
49 years, female, white, stage:Stage IV, alive, 67 days
904.5
TCGA-24-2271-01A
55 years, female, asian, stage:Stage IIIC, dead, 962 days
901.3
TCGA-04-1356-01A
62 years, female, white, stage:Stage IIC, dead, 1499 days
893.1
TCGA-25-2392-01A
75 years, female, white, stage:Stage IV, dead, 31 days
862.2
TCGA-61-2012-01A
81 years, female, white, stage:Stage IIC, alive, 932 days
851.3
TCGA-13-1512-01A
49 years, female, white, stage:Stage IIIC, alive, 442 days
756.9
TCGA-24-2293-01A
47 years, female, white, stage:'--, dead, 506 days
755.0
TCGA-24-2289-01A
68 years, female, white, stage:Stage IV, dead, 2049 days
The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.
The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".
Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.
Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.
& Survival analysisi
Kaplan-Meier plots summarize results from analysis of correlation between mRNA expression level and patient survival. Patients were divided based on level of expression into one of the two groups "low" (under cut off) or "high" (over cut off). X-axis shows time for survival (years) and y-axis shows the probability of survival, where 1.0 corresponds to 100 percent.
RPL24 is not prognostic in Ovary Serous Cystadenocarcinoma (validation)
Stage:
Survival analysis
Current cut offi
Current cut-off shows the cut-off (FPKM) currently selected. It may be changed manually. When the current cut-off is changed, the vertical dashed line indicating cut-off, the interactive survival scatter plot and the Kaplan-Meier curve will be automatically adjusted to show results accordingly.
:
Best expression cut offi
Based on the FPKM value of each gene, patients were classified into two groups and association between prognosis (survival) and gene expression (FPKM) was examined. The best expression cut-off refers the FPKM value that yields maximal difference with regard to survival between the two groups at the lowest log-rank P-value. Best expression cut-off was selected based on survival analysis .
When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the best expression cut-off.
Median expression refers to the median FPKM value calculated based on the gene expression (FPKM) data from all patients in this dataset. When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the median expression.
Median follow up time refers to the median time (years) after diagnosis with this type of cancer, based on clinical data from all patients in this dataset.
: N/A
P scorei
Log-rank P value for Kaplan-Meier plot showing results from analysis of correlation between mRNA expression level and patient survival.
N/A
5-year survival highi
5-year survival for patients with higher expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
5-year survival lowi
5-year survival for patients with lower expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
TCGA RNA samplesi
RNA-seq data is reported as average FPKM (number Fragments Per Kilobase of exon per Million reads), generated by the The Cancer Genome Atlas (TCGA) .
Normal distribution across the dataset is visualized with box plots, shown as median and 25th and 75th percentiles. Points are displayed as outliers if they are above or below 1.5 times the interquartile range. FPKM values of the individual samples are presented next to the box plot.
Average pTPM
1904.1
Number of samples
81
Samples
Sample
Description
pTPM
DO46356
68 years, female, NA, stage:III, dead, 911 days
5267.5
DO46333
58 years, female, NA, stage:III, dead, 359 days
4128.9
DO46390
65 years, female, NA, stage:III, dead, 374 days
3935.6
DO46611
52 years, female, NA, stage:III, dead, 734 days
3674.1
DO46400
70 years, female, NA, stage:III, dead, 719 days
3566.4
DO46384
55 years, female, NA, stage:III, dead, 614 days
3234.8
DO46331
72 years, female, NA, stage:III, dead, 612 days
2879.7
DO46352
60 years, female, NA, stage:III, dead, 677 days
2874.7
DO46370
54 years, female, NA, stage:III, dead, 1727 days
2767.8
DO46588
74 years, female, NA, stage:III, dead, 438 days
2703.8
DO46334
77 years, female, NA, stage:III, dead, 496 days
2672.7
DO46463
49 years, female, NA, stage:III, dead, 2451 days
2667.5
DO46591
58 years, female, NA, stage:III, dead, 195 days
2632.3
DO46402
77 years, female, NA, stage:III, dead, 511 days
2556.3
DO46568
66 years, female, NA, stage:III, dead, 320 days
2478.7
DO46538
57 years, female, NA, stage:III, dead, 1527 days
2421.0
DO46606
73 years, female, NA, stage:III, alive, 804 days
2387.1
DO46576
75 years, female, NA, stage:III, alive, 133 days
2373.6
DO46338
59 years, female, NA, stage:III, dead, 596 days
2352.3
DO46326
51 years, female, NA, stage:III, dead, 701 days
2346.5
DO46378
59 years, female, NA, stage:III, alive, 843 days
2335.0
DO46394
61 years, female, NA, stage:IV, dead, 1039 days
2238.6
DO46366
65 years, female, NA, stage:III, dead, 2054 days
2224.1
DO46597
60 years, female, NA, stage:III, dead, 393 days
2171.4
DO46523
52 years, female, NA, stage:IV, alive, 1873 days
2167.2
DO46374
69 years, female, NA, stage:III, dead, 1409 days
2151.5
DO46342
67 years, female, NA, stage:III, dead, 1398 days
2132.9
DO46581
66 years, female, NA, stage:III, dead, 408 days
2118.1
DO46586
55 years, female, NA, stage:III, dead, 1019 days
2103.5
DO46362
61 years, female, NA, stage:III, dead, 1639 days
2096.1
DO46392
48 years, female, NA, stage:III, dead, 628 days
2079.1
DO46518
62 years, female, NA, stage:III, alive, 2960 days
2049.4
DO46398
66 years, female, NA, stage:III, alive, 437 days
2012.4
DO46571
61 years, female, NA, stage:III, dead, 243 days
1966.3
DO46388
74 years, female, NA, stage:III, dead, 413 days
1944.9
DO46404
55 years, female, NA, stage:III, dead, 690 days
1925.7
DO46330
60 years, female, NA, stage:III, dead, 684 days
1894.4
DO46533
46 years, female, NA, stage:III, alive, 3667 days
1893.7
DO46561
52 years, female, NA, stage:III, dead, 195 days
1892.6
DO46350
66 years, female, NA, stage:III, dead, 886 days
1886.1
DO46380
51 years, female, NA, stage:III, dead, 1423 days
1877.4
DO46508
50 years, female, NA, stage:III, dead, 2101 days
1855.7
DO46364
45 years, female, NA, stage:III, dead, 806 days
1842.5
DO46551
58 years, female, NA, stage:III, dead, 1055 days
1761.3
DO46443
59 years, female, NA, stage:III, dead, 2464 days
1734.9
DO46360
58 years, female, NA, stage:IV, dead, 1759 days
1715.9
DO46376
58 years, female, NA, stage:III, dead, 1430 days
1703.2
DO46560
45 years, female, NA, stage:IV, dead, 286 days
1622.8
DO46458
67 years, female, NA, stage:IV, alive, 3787 days
1622.8
DO46396
64 years, female, NA, stage:III, dead, 583 days
1618.4
DO46566
78 years, female, NA, stage:III, dead, 673 days
1597.8
DO46327
54 years, female, NA, stage:III, dead, 184 days
1582.8
DO46408
56 years, female, NA, stage:III, dead, 489 days
1581.8
DO46328
52 years, female, NA, stage:III, dead, 972 days
1566.0
DO46513
54 years, female, NA, stage:IV, dead, 1883 days
1560.8
DO46453
66 years, female, NA, stage:III, dead, 3294 days
1395.1
DO46348
58 years, female, NA, stage:IV, dead, 287 days
1388.7
DO46354
73 years, female, NA, stage:III, dead, 843 days
1360.8
DO46346
54 years, female, NA, stage:III, dead, 1187 days
1348.5
DO46332
56 years, female, NA, stage:III, dead, 689 days
1338.8
DO46368
57 years, female, NA, stage:III, dead, 2879 days
1308.7
DO46546
73 years, female, NA, stage:III, dead, 1889 days
1300.7
DO46493
62 years, female, NA, stage:IV, alive, 839 days
1296.8
DO46386
49 years, female, NA, stage:III, dead, 1162 days
1288.8
DO46432
56 years, female, NA, stage:III, alive, 2218 days
1279.3
DO46336
70 years, female, NA, stage:IV, dead, 664 days
1223.5
DO46528
56 years, female, NA, stage:III, alive, 6139 days
1170.4
DO46325
54 years, female, NA, stage:III, dead, 477 days
1167.5
DO46602
74 years, female, NA, stage:III, dead, 205 days
1124.0
DO46448
45 years, female, NA, stage:III, dead, 654 days
1040.1
DO46372
39 years, female, NA, stage:III, dead, 1326 days
1002.6
DO46382
62 years, female, NA, stage:IV, dead, 311 days
935.5
DO46340
62 years, female, NA, stage:III, dead, 616 days
893.7
DO46438
55 years, female, NA, stage:IV, alive, 2227 days
892.9
DO46344
46 years, female, NA, stage:III, dead, 642 days
887.7
DO46412
64 years, female, NA, stage:III, dead, 597 days
811.4
DO46358
60 years, female, NA, stage:III, dead, 423 days
796.4
DO46468
67 years, female, NA, stage:III, alive, 2776 days
766.8
DO46428
59 years, female, NA, stage:IV, alive, 2644 days
641.6
DO46329
52 years, female, NA, stage:III, dead, 1699 days
630.1
DO46436
58 years, female, NA, stage:III, alive, 3193 days
498.1
Show allShow less
OVARY SEROUS CYSTADENOCARCINOMA - Protein relative expression (CPTAC)
Number of samples
108
Samples
Sample ID
Sample type
nRPX
a03d1103-b809-42c4-ad5c-5aff58_D2
Tumor
1.7
318d53c3-216b-4de1-a098-77d6dd_D2
Tumor
1.5
eb0a53df-7620-4024-8d2d-051142_D2
Tumor
1.4
76e77c6b-c80e-4391-bdbb-e1dcea_D2
Tumor
1.4
347e379b-77c0-4dd3-aa25-18c9d1_D2
Tumor
1.4
5c3971ee-87c7-4dff-b66e-f18892_D2
Tumor
1.4
d109a3c0-350e-47f5-bda0-61899c_D2
Tumor
1.4
7069e990-4a4e-4984-a66d-4d835a_D2
Tumor
1.4
1b2ab076-c72f-4bbe-b9f9-657d24_D2
Tumor
1.4
9c8e78bf-b03e-4ba0-9909-5ff070_D2
Tumor
1.4
91b287fd-eadb-442d-abcd-20b741_D2
Tumor
1.3
2dc28da8-7ff1-4b9b-b5bd-17cc25_D2
Tumor
1.3
50997c44-1c8b-4d34-b535-4a6cc2_D2
Tumor
1.3
a8853382-b726-4ce8-98d5-ca89df_D2
Tumor
1.3
4ccb249a-6722-491e-97e9-e3b4e7_D2
Tumor
1.3
2563cb02-d58a-4286-8634-7502cd_D2
Tumor
1.3
3a380577-c134-47ba-a1ce-988d7c_D2
Tumor
1.3
3490835c-c004-45ed-91f3-7c206f_D2
Tumor
1.2
558333b0-ea23-4303-9e3c-4932b1_D2
Tumor
1.2
52c064a7-78d9-4a1a-85b4-27c6d1_D2
Tumor
1.2
2433b136-fc7b-4cea-b958-bc6efb_D2
Tumor
1.2
5ea22f5e-307b-491d-801f-8b7fa6_D2
Tumor
1.1
d38f40fb-dd78-43b2-8b7b-4b6977_D2
Tumor
1.1
3d3e1888-d67e-4c69-ba83-112d0f_D2
Tumor
1.1
1de8d3d8-fc0e-4be0-8aa7-127c7b_D2
Tumor
1.1
62f5840e-6cd7-4200-b651-645e53_D2
Tumor
1.1
161317f3-1a39-438e-af45-cd2502_D2
Tumor
1.1
2115808b-6a0d-49bc-a8d7-b83bde_D2
Tumor
1.1
e9d416e7-f661-400a-896e-388545_D2
Tumor
1.1
8d78194e-fbef-4819-a7b5-b73ae9_D2
Tumor
1.1
41d0619e-b299-42e2-ac32-29e784_D2
Tumor
1.1
ce1e5dfc-2ef1-4633-af93-5ea4d9_D2
Tumor
1.1
256ac9f5-1e19-44b4-92fb-fef3fc_D2
Tumor
1.0
927f0958-db5a-4bc5-92b7-2a3695_D2
Tumor
1.0
fe83e13f-9754-403b-8f74-d6caf8_D2
Tumor
1.0
15524912-685a-47ce-a824-567848_D2
Tumor
1.0
7d953d1d-84b6-4ecd-b1d7-1ed865_D2
Tumor
1.0
74a45e5a-a35a-4c60-a4b4-f3f5ea_D2
Tumor
1.0
69d552be-7cb2-4bb4-b602-a27b3e_D2
Tumor
0.9
80873a0c-1f40-4d51-bab1-3f2071_D2
Tumor
0.9
0cc794c3-5bf5-4621-b238-58a0f6_D2
Tumor
0.9
6530147a-efe9-4df6-ac2f-03ece3_D2
Tumor
0.9
79b60f32-6cca-4cb6-9a1e-22a3ac_D2
Tumor
0.9
af95e2c6-25c4-4ab8-bf06-3e15ff_D2
Tumor
0.9
e7b656bf-3c34-4ba1-bdf3-c7eefe_D2
Tumor
0.9
c17b0ff9-9057-4848-a0cc-abb25f_D2
Tumor
0.8
27f3ca2d-a86f-479d-8e7e-5307c7_D2
Tumor
0.8
1c9145ad-1981-4871-aa7e-8b11de_D2
Tumor
0.8
3dcf8b3c-c0c5-4dfa-9543-5d30fb_D2
Tumor
0.8
fbb41c94-aabd-49cc-90b2-882c3e_D2
Tumor
0.8
627e6e36-3dca-4ee5-9755-6f3510_D2
Tumor
0.8
2224c03f-b7b1-4368-887e-2b4cdf_D2
Tumor
0.8
9b90eb78-2f50-4aeb-b010-d642f9_D2
Tumor
0.8
8234f8ea-bdbd-45b0-bd0b-16f1e7_D2
Tumor
0.8
f6c215ea-5381-4521-bb61-be8e97_D2
Tumor
0.7
285fed94-1495-448e-879b-b55de9_D2
Tumor
0.7
2f901c90-617e-46da-9fac-d68369_D2
Tumor
0.7
eb3f3494-7057-4afe-b212-e6e9a3_D2
Tumor
0.7
1772e913-f62e-446a-8cf3-720348_D2
Tumor
0.7
d4791079-c826-4fc7-9d9b-ee20ba_D2
Tumor
0.6
9e0d47e0-f633-468b-b82b-4d752d_D2
Tumor
0.6
28d0abdb-f682-4bd3-9425-a9c508_D2
Tumor
0.6
10c2d629-0287-4511-ac25-f29031_D2
Tumor
0.6
092af714-b97a-457c-b0e9-8c20e8_D2
Normal
0.6
46c73531-f531-4ec3-97fe-b39d9d_D2
Tumor
0.6
51a4ce2f-4166-4c6b-a7e0-942d0a_D2
Tumor
0.6
42d860a3-8a0c-4c44-a09a-9ad8cf_D2
Tumor
0.5
1a10c200-3895-4648-b951-94f99f_D2
Tumor
0.5
49bd51fe-48a1-4828-b66e-b30c38_D2
Tumor
0.5
bd266bdd-12e4-42cb-9c49-911bfc_D2
Tumor
0.4
35a345a4-e954-4c81-ae3f-7797cd_D2
Tumor
0.4
3946a96c-e0ae-442f-83b4-a9350e_D2
Tumor
0.4
08296da7-70ea-44df-8646-09f2cc_D2
Tumor
0.4
340a3769-3031-41ae-bb08-a2f696_D2
Normal
0.4
cfd76f9a-ce60-4ec7-8e6b-a8fc31_D3
Tumor
0.3
3fbf076a-824b-4eac-b6dc-bf5e59_D2
Normal
0.3
1556af7e-c2ae-4fce-9aae-87c459_D1_D2
Normal
0.3
0c87932d-b6fd-4eb5-b86a-a34d07_D2
Tumor
0.3
31c15e30-21d4-4843-bd4a-9cd0d8_D2
Normal
0.3
e3ebe010-cd31-4b5d-8fcb-b7103b_D2
Tumor
0.2
9a7a86d3-bbf2-4d36-941d-c75c03_D1_D2
Tumor
0.2
8e17b45e-6a06-4e4e-913d-7b1edb_D2
Tumor
0.2
1db5574d-aca7-403c-8100-6e705f_D2
Normal
0.2
2ed8beb2-bc63-4bad-b5fe-1916a0_D2
Tumor
0.2
05387aad-2a1f-42c2-8d6f-950598_D3
Tumor
0.1
51c1c79e-5a8e-4b0a-bf92-1c0cab_D2
Tumor
0.1
61f76fe6-a1c6-41b8-bdc2-2f9209_D2
Normal
0.1
2b73e01c-347a-4dae-a71d-752aeb_D2
Normal
0.1
efc971f8-54c5-4531-a792-705ecf_D2
Tumor
0.1
3e746bea-ed68-40e6-b348-6ddf08_D2
Normal
0.0
7c7ce2d7-6c8a-424e-8e6c-d14ad1_D2
Tumor
0.0
685ec3c2-e67a-40d3-9eb3-aa01c9_D1_D2
Normal
0.0
7edfd606-4bee-4529-9fec-1ca7f0_D2
Normal
-0.1
6e209757-a7f4-45af-b5f3-2ebc02_D2
Normal
-0.1
2b4ce90c-8036-4207-ac3e-54a76f_D2
Tumor
-0.1
6319b36b-533c-4e86-8e12-80552e_D3
Tumor
-0.2
8ed739dd-ae0f-4881-971a-db3cf4_D1_D2
Normal
-0.3
994f9b8e-46cb-413f-8ec8-2c2fed_D2
Normal
-0.3
a65d8e76-640f-4341-a561-afbb57_D2
Normal
-0.3
21efd60f-6a31-4b98-9477-16a905_D2
Normal
-0.3
1abbcb28-f221-4cd4-8c01-37b9bb_D1_D2
Normal
-0.4
b9c1f22e-61f7-45ed-b3b4-5094c7_D2
Normal
-0.4
e23eb014-69c1-460a-b9d4-9786c8_D2
Normal
-0.5
a583d3ff-8165-43e9-b764-23b7ef_D1_D2
Normal
-0.6
a3a26070-fb84-406a-8280-d555e6_D2
Normal
-0.7
b22659b9-e12c-4725-a7db-a833de_D1_D2
Normal
-0.7
0745488e-0bfb-4d1f-8228-dedf76_D1_D2
Normal
-0.8
e6850782-fd2a-4c53-b682-1852fe_D2
Tumor
-1.0
Show allShow less
OVARIAN CANCER - Protein expressioni
A mouse-over function shows sample information and annotation data. Click on an image to view it in a full screen mode. Samples can be filtered based on level of antibody staining by selecting one or several of the following categories: high, medium, low and not detected. The assay and annotation is described here.
Note that samples used for immunohistochemistry by the Human Protein Atlas do not correspond to samples in the TCGA dataset.
Antibody stainingi
Antibody staining in the annotated cell types in the current human tissue is reported as not detected, low, medium, or high, based on conventional immunohistochemistry profiling in selected tissues. This score is based on the combination of the staining intensity and fraction of stained cells.
Each image is clickable and will lead to virtual microscopy that enables deeper exploration of all samples and also displays staining intensity scores, fraction scores and subcellular localization as well as patient and tissue information for each sample.
The Human Protein Atlas project is funded
